MasterCard Inc vs UnitedHealth Group Inc — how do they compare? MasterCard Inc trades at $589.14 (market cap $503.50B), while UnitedHealth Group Inc trades at $379.3 (market cap $332.96B). The key difference: MasterCard Inc is the larger of the two by market cap, and UnitedHealth Group Inc pays the higher dividend (2.5%). Which is the better fit depends on your goals — on Pluang, investors hold MasterCard Inc for 134 Days and UnitedHealth Group Inc for 97 Days on average.
| MA | UNH | |
|---|---|---|
Market Cap | $503.50B | $332.96B |
Volume | 3,390,859 | 7,273,749 |
Sector | Financials | Health |
52-Week High | $599.86 | $436.35 |
52-Week Low | $471.55 | $259.02 |
Typical Hold Time | 134 Days | 97 Days |
Enterprise Value | $516.53B | $374.82B |
Dividend Yield | 0.61% | 2.5% |
Signals from Pluang's Aura AI — not financial advice
Mastercard (MA) trades at $574.76, up 0.82% with strong bullish technical signals. The company demonstrates robust fundamentals with 2025 revenue of $32.79B and net income of $14.97B, maintaining exceptional profit margins above 45%. Recent earnings consistently beat expectations, with Q2 2026 EPS of $5.04 surpassing the $4.77 estimate. Analyst consensus remains overwhelmingly positive with 80% buy ratings and a $666.67 price target.
Mastercard presents a compelling growth opportunity with expanding digital payment adoption and strong financial performance. Key risks include payment industry disruption from stablecoins and AI-driven alternatives, though the company's aggressive innovation strategy positions it well. The stock trades at premium valuations (P/E 31.6) but justifies this with consistent earnings growth and market leadership.
UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.
UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →